Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Tvardi Therapeutics Inc., 3 years.
Tvardi Therapeutics Inc.
Director
Acumen Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2024 | Tvardi Therapeutics Inc. | Grant or award | +150,647 | — | — |
| Aug 17, 2023 | Acumen Pharmaceuticals Inc. | Option exercise | +39,149 | $0.72 | $28,187 |
| Aug 17, 2023 | Acumen Pharmaceuticals Inc. | Open-market sale | −39,149 | $6.48 | $253,686 |
| Aug 17, 2023 | Acumen Pharmaceuticals Inc. | Option exercise | +2,800 | $1.19 | $3,332 |
| Aug 17, 2023 | Acumen Pharmaceuticals Inc. | Open-market sale | −2,800 | $6.66 | $18,648 |
| Jun 1, 2023 | Tvardi Therapeutics Inc. | Grant or award | +32,362 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.